VivoSeq
Infectious Disease

Viral Infection

1

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Viral Infection is an early-stage landscape with 1 program across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

17/100

Pipeline

Programs by Phase

Preclinical
No programs
Phase 11

Hydrovax-001b WNV

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

6

clinical trials

Completed2 · 33%
Active, not recruiting2 · 33%
No longer available1 · 17%
Terminated1 · 17%

Clinical Trials

Trial Activity

6 trials

A Phase 1 Trial to Evaluate the Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine, HydroVax-001B WNV in Healthy Adults
Active, not recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT06745921·30 enrolled
COMPArative Study of the Consequence on innaTe Immune Response du to Bacterial or Viral Infection in Patients Admitted to Intensive Care Unit
Active, not recruiting·UUniversity Hospital, Limoges·Preclinical·NCT05671159·38 enrolled
Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection
Completed·SSingapore General Hospital·Phase 2·NCT04267809·32 enrolled
Oral Ivermectin for Chikungunya Viral Infection
Completed·PPrince of Songkla University·Phase 3·NCT06259383·120 enrolled
Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination
Terminated·RRockefeller University·N/A·NCT02590068·14 enrolled
Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)
No longer available·—·N/A·NCT01945619

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)